Raia Drogasil S.A. (RADLY)
USD 3.66
(-1.4%)
USD 3.66
(-1.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 20.09 Billion BRL | 16.93% |
| 2022 | 17.18 Billion BRL | 16.31% |
| 2021 | 14.77 Billion BRL | 6.85% |
| 2020 | 13.82 Billion BRL | 12.9% |
| 2019 | 12.24 Billion BRL | 66.6% |
| 2018 | 7.35 Billion BRL | 13.73% |
| 2017 | 6.46 Billion BRL | 14.22% |
| 2016 | 5.65 Billion BRL | 20.43% |
| 2015 | 4.69 Billion BRL | 16.05% |
| 2014 | 4.04 Billion BRL | 12.04% |
| 2013 | 3.61 Billion BRL | 8.2% |
| 2012 | 3.34 Billion BRL | 5.42% |
| 2011 | 3.16 Billion BRL | 243.53% |
| 2010 | 922.28 Million BRL | 26.01% |
| 2009 | 731.91 Million BRL | 23.85% |
| 2008 | 590.95 Million BRL | 4.14% |
| 2007 | 567.46 Million BRL | 89.73% |
| 2006 | 299.09 Million BRL | 32.68% |
| 2005 | 225.42 Million BRL | 15.67% |
| 2004 | 194.89 Million BRL | 17.23% |
| 2003 | 166.25 Million BRL | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 21.01 Billion BRL | 0.26% |
| 2024 Q1 | 20.65 Billion BRL | 2.77% |
| 2023 Q1 | 18.24 Billion BRL | 6.19% |
| 2023 FY | 20.09 Billion BRL | 16.93% |
| 2023 Q3 | 19.38 Billion BRL | 9.25% |
| 2023 Q2 | 17.74 Billion BRL | -2.76% |
| 2023 Q4 | 20.09 Billion BRL | 3.65% |
| 2022 Q3 | 16.52 Billion BRL | 2.19% |
| 2022 Q4 | 17.18 Billion BRL | 4.01% |
| 2022 FY | 17.18 Billion BRL | 16.31% |
| 2022 Q1 | 15.53 Billion BRL | 5.15% |
| 2022 Q2 | 16.16 Billion BRL | 4.07% |
| 2021 FY | 14.77 Billion BRL | 6.85% |
| 2021 Q1 | 14.14 Billion BRL | 2.33% |
| 2021 Q2 | 14.01 Billion BRL | -0.93% |
| 2021 Q3 | 14.4 Billion BRL | 2.77% |
| 2021 Q4 | 14.77 Billion BRL | 2.56% |
| 2020 Q1 | 13.02 Billion BRL | 6.36% |
| 2020 FY | 13.82 Billion BRL | 12.9% |
| 2020 Q4 | 13.82 Billion BRL | 6.0% |
| 2020 Q3 | 13.04 Billion BRL | 2.27% |
| 2020 Q2 | 12.75 Billion BRL | -2.08% |
| 2019 Q4 | 12.24 Billion BRL | -2.66% |
| 2019 FY | 12.24 Billion BRL | 66.6% |
| 2019 Q1 | 11.18 Billion BRL | 52.17% |
| 2019 Q2 | 11.09 Billion BRL | -0.8% |
| 2019 Q3 | 12.58 Billion BRL | 13.37% |
| 2018 FY | 7.35 Billion BRL | 13.73% |
| 2018 Q4 | 7.35 Billion BRL | 3.31% |
| 2018 Q3 | 7.11 Billion BRL | 5.27% |
| 2018 Q2 | 6.75 Billion BRL | 4.05% |
| 2018 Q1 | 6.49 Billion BRL | 0.5% |
| 2017 Q1 | 5.73 Billion BRL | 1.28% |
| 2017 Q2 | 6 Billion BRL | 4.83% |
| 2017 FY | 6.46 Billion BRL | 14.22% |
| 2017 Q3 | 6.3 Billion BRL | 5.02% |
| 2017 Q4 | 6.46 Billion BRL | 2.45% |
| 2016 Q2 | 4.86 Billion BRL | 1.81% |
| 2016 FY | 5.65 Billion BRL | 20.43% |
| 2016 Q3 | 5.31 Billion BRL | 9.42% |
| 2016 Q4 | 5.65 Billion BRL | 6.38% |
| 2016 Q1 | 4.77 Billion BRL | 1.62% |
| 2015 Q2 | 4.13 Billion BRL | -0.51% |
| 2015 Q4 | 4.69 Billion BRL | 7.9% |
| 2015 FY | 4.69 Billion BRL | 16.05% |
| 2015 Q1 | 4.15 Billion BRL | 2.66% |
| 2015 Q3 | 4.35 Billion BRL | 5.3% |
| 2014 FY | 4.04 Billion BRL | 12.04% |
| 2014 Q4 | 4.04 Billion BRL | 6.59% |
| 2014 Q3 | 3.79 Billion BRL | 4.39% |
| 2014 Q2 | 3.63 Billion BRL | 3.0% |
| 2014 Q1 | 3.53 Billion BRL | -2.24% |
| 2013 Q1 | 3.24 Billion BRL | -2.91% |
| 2013 Q4 | 3.61 Billion BRL | 9.56% |
| 2013 Q3 | 3.29 Billion BRL | -0.53% |
| 2013 Q2 | 3.31 Billion BRL | 2.25% |
| 2013 FY | 3.61 Billion BRL | 8.2% |
| 2012 Q4 | 3.34 Billion BRL | 4.84% |
| 2012 FY | 3.34 Billion BRL | 5.42% |
| 2012 Q3 | 3.18 Billion BRL | 2.5% |
| 2012 Q1 | 3.12 Billion BRL | -1.49% |
| 2012 Q2 | 3.1 Billion BRL | -0.41% |
| 2011 FY | 3.16 Billion BRL | 243.53% |
| 2011 Q4 | 3.16 Billion BRL | 213.34% |
| 2011 Q3 | 1.01 Billion BRL | 4.03% |
| 2011 Q2 | 971.97 Million BRL | -1.88% |
| 2011 Q1 | 990.61 Million BRL | 7.41% |
| 2010 Q2 | 699.9 Million BRL | -4.1% |
| 2010 Q3 | 780.5 Million BRL | 11.52% |
| 2010 Q1 | 729.79 Million BRL | -0.29% |
| 2010 Q4 | 922.28 Million BRL | 18.16% |
| 2010 FY | 922.28 Million BRL | 26.01% |
| 2009 FY | 731.91 Million BRL | 23.85% |
| 2009 Q4 | 731.91 Million BRL | 0.0% |
| 2008 FY | 590.95 Million BRL | 4.14% |
| 2007 FY | 567.46 Million BRL | 89.73% |
| 2006 FY | 299.09 Million BRL | 32.68% |
| 2005 FY | 225.42 Million BRL | 15.67% |
| 2004 FY | 194.89 Million BRL | 17.23% |
| 2003 FY | 166.25 Million BRL | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | 220.00 USD | -9133823536.364% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 567.74 Million USD | -3439.356% |
| Café Serendipity Holdings, Inc. | 1.04 Million USD | -1922655.683% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 501.27 Thousand USD | -4008528.329% |
| HealthWarehouse.com, Inc. | 3.2 Million USD | -626185.63% |
| LIGAND PHARMACEUTICAL INC | 787.21 Million USD | -2452.592% |
| MedGen, Inc. | 0.79 USD | -2543596455596.203% |
| Omni Health, Inc. | 5.53 Million USD | -363167.526% |
| Oxford Investments Holdings Inc. | 451.08 Thousand USD | -4454623.653% |
| Pineapple, Inc. | 7.83 Million USD | -256218.241% |
| ScripsAmerica, Inc. | 5.64 Million USD | -355929.125% |